A novel prognostic score effectively stratifies hepatocellular carcinoma patients with microvascular invasion based on early recurrence factors. Evaluating 265 patients, it incorporates serum alpha-fetoprotein levels, hepatitis B e antigen status, and presence of satellite nodules. Higher scores correlate with significantly lower three-year recurrence-free and overall survival rates. The findings underscore the score’s predictive power beyond liver cirrhosis status, providing critical insights for post-hepatectomy patient management.
Journal Article by Li H, Shen J and Wen T in Langenbecks Arch Surg
© 2025. The Author(s).